Tine Vanschoonbeek
Head of Pharmacy
Tine Vanschoonbeek is qualified as a pharmacist, majoring in drug development, and within the operation of the Anima Research Centre is primarily responsible for the operation of the pharmacy. She is specifically trained in the preparation and blinding process of all study medication required for this purpose, as well as in the management of the entire stock of these medications.
Tine is also lead author of Phase 0 bio-marker studies on behalf of Janssen Pharmaceutica and others.
Finally, Tine is also responsible for the development, execution and analysis of internal studies on ANT01, an innovative product within the context of cognitive difficulties due to depression, discovered by Dr Erik Buntinx.